Biomedical Engineering Reference
In-Depth Information
OMOM
MOMO
AuL
OMOM
(JohnPhos)AuNTf
2
(3 mol%)
O
O
n
-Bu
O
O
O
n
-Bu (3 equiv)
CH
2
Cl
2
, rt, 2 h
O
n
-Bu
R
R
R
89a
90
91a
R = H
89b
(R = H, 82 %)
91b
R = Me
(R = Me, 94%)
H
H
OH
NMe
2
O
O
Me
H
NMe
2
. HCl
92
93
SCHEME 4.26
C-C bonds has been recently described by Liu and coworkers [23]. These authors
have reported that the treatment of alkynes
89a
and
89b
with a catalytic amount of
gold catalyst [(JohnPhos)AuNTf
2
] in the presence of
n
-butyl vinyl ether allows the
formation of the new oxabicyclononadiene structures
91a
and
91b
by a formal [4+2]-
cycloaddition proceeding on an
s
-
trans
-oxonium of type
(Scheme 4.26). This
gold-catalyzed transformation might be useful to synthesize the bioactive molecules
92
90
and
93
, which exhibit NCS activity and HIV-1 inhibitory effects.
4.3. GOLD-CATALYZED FORMATION
OF NITROGEN-CONTAINING HETEROCYCLES
Analogously to the formation of oxygen-containing heterocycles, nitrogen-contain-
ing heterocycles can be produced by the addition of a nitrogen nucleophilic species on
an alkyne or an allene-ene possessing. They can be alternatively obtained by the
cycloisomerization of an enyne or an allene-ene possessing a nitrogen atom in their
linker (formation of a new C-C bond). These transformations have been mainly
employed for the synthesis of alkaloids possessing a structural unit derived from a
pyrrolidine, a piperidine, a pyrrole, or a pyridine (Scheme 4.27).
C-N bond formation
C-C bond formation
n
n
HN
HN
G
G
m
N
G
n
N
G
N
N
G
N
N
G
G
N
G
N
G
N
G
n
N
G
N
G
N
G
SCHEME 4.27
Search WWH ::
Custom Search